ALL libraries (COBIB.SI union bibliographic/catalogue database)
13.
Z dokazi podprto zdravljenje covida-19 z zdravili
Knez, Lea, 1981- ...
Danes že imamo na voljo prvo v Evropski Uniji registrirano zdravilo za zdravljenje covida-19, remdesivir. Imamo tudi zanesljive dokaze o zmanjšanju smrtnosti najhuje bolnih bolnikov s covidom-19 ob ...zdravljenju z nizkimi odmerki kortikosteroidov in imamo na voljo rezultate dobro zasnovanih randomiziranih kliničnih raziskav, ki niso potrdile učinkovitosti številnih protivirusnih zdravil, pogosto predpostavljene na teoretičnih osnovah in opisih primerov. V prispevku opisujemo najbolj odmevna zdravila pri COVID-19: remdesivir, lopinavir z ritonavirjem, favipiravir in (hidroksi)klorokin. Zgodbo o (hidroksi)klorokinu opisujemo kot dokaz, kako se lahko le preko kliničnih raziskav, tudi v Sloveniji, premaknemo iz točke, ko >>mislimo<<, k temu, da >>vemo<<, katera zdravila so varna in učinkovita pri covidu-19.
It was not necessary to add the material to the shelf.
Bibliographic material was successfully added on shelf.
Adding bibliographical material on shelf was not successful.
Material is already on the shelf.
Permalink
URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year
Impact factor
Edition
Category
Classification
JCR
SNIP
JCR
SNIP
JCR
SNIP
JCR
SNIP
Select the library membership card:
DRS,
in which the journal is indexed
Database name
Field
Year
Links to authors' personal bibliographies
Links to information on researchers in the SICRIS system
Subject headings in COBISS General List of Subject Headings
Select pickup location
The material from the parent unit is free. If the material is delivered to the pickup location from another unit, the library may charge you for this service.
